AventaCell Competitors and Similar CompaniesClear all
AventaCell's competitors and similar companies include Solarea Bio, Immune Regulation, Danaher and Sanofi.
 AventaCell AventaCell BioMedical is a company that develops human-derived products for use in cell culture and tissue regeneration. |  Solarea Bio Solarea Bio is a biotechnology company developing microbiome-based therapeutics to treat human diseases. |  Immune Regulation Immune Regulation is a clinical-stage biotech company providing technologies for resetting the immune system and developing therapies for inflammatory and immunological diseases. |  Danaher Danaher (formerly known as Diversified Mortgage Investors) is a life sciences and diagnostics company that manages and operates its group companies. |  Sanofi Sanofi is a healthcare company engaged in the research, development, manufacture, and marketing of therapeutic solutions. | |
Founding Date | Founding Date 2015 | Founding Date 2017 | Founding Date 2011 | Founding Date 1984 | Founding Date 1994 |
Type | Type Private | Type Private | Type Private | Type Public | Type Public |
Tags | |||||
Locations | Locations Atlanta, US HQ | Locations Cambridge, US HQ | Locations Great Shelford, GB HQ | Locations Washington, US HQ Mount Waverley, AU Vienna, AT Ghent, BE Sao Paolo, BR Vancouver, CA Shanghai, CN see more | Locations Paris, FR HQ Hydra, DZ Buenos Aires, AR Macquarie Park, AU Melbourne, AU Virginia, AU Wien, AT see more |
Employees | Employees 14 | Employees 205% increase | Employees 1810% decrease | Employees 61,000 | Employees 82,878 |
Valuation ($) | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 175.3 b | Valuation ($) 141.1 b |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) $24.6b (FY, 2025) | Revenue (est.) €45.4b (FY, 2025) |
Cost of goods | Cost of goods N/A | Cost of goods N/A | Cost of goods N/A | Cost of goods $10b (FY, 2025) | Cost of goods €11.6b (FY, 2025) |
Gross profit | Gross profit N/A | Gross profit N/A | Gross profit N/A | Gross profit $14.5b (FY, 2025) | Gross profit €37.6b (FY, 2025) |
Net income | Net income N/A | Net income N/A | Net income N/A | Net income $3.6b (FY, 2025) | Net income €8b (FY, 2025) |
Funding | |||||
Latest funding round | Latest funding round N/A | Latest funding round $ 11.2m (over 5 years ago) | Latest funding round $ 52.4m (over 5 years ago) | Latest funding round N/A | Latest funding round N/A |
Total funding raised | Total funding raised N/A | Total funding raised $ 11.2m | Total funding raised $ 52.4m | Total funding raised N/A | Total funding raised $ 310m |
For sources of this data, please see the company profile
View Company Profiles
Solarea Bio
HQ
Cambridge, US
Employees
20↑ 5% increase
Solarea Bio is a biotechnology company developing microbiome-based therapeutics to treat human diseases.
View companyImmune Regulation
HQ
Great Shelford, GB
Employees
18↓ 10% decrease
Immune Regulation is a clinical-stage biotech company providing technologies for resetting the immune system and developing therapies for inflammatory and immunological diseases.
View companyDanaher
HQ
Washington, US
Employees
61,000
Danaher (formerly known as Diversified Mortgage Investors) is a life sciences and diagnostics company that manages and operates its group companies.
View companySanofi
HQ
Paris, FR
Employees
82,878
Sanofi is a healthcare company engaged in the research, development, manufacture, and marketing of therapeutic solutions.
View company